[HTML][HTML] Properties of FDA-approved small molecule protein kinase inhibitors: A 2023 update

R Roskoski Jr - Pharmacological research, 2023 - Elsevier
Owing to the dysregulation of protein kinase activity in many diseases including cancer, this
enzyme family has become one of the most important drug targets in the 21 st century. There …

Properties of FDA-approved small molecule protein kinase inhibitors: A 2020 update

R Roskoski Jr - Pharmacological research, 2020 - Elsevier
Because genetic alterations including mutations, overexpression, translocations, and
dysregulation of protein kinases are involved in the pathogenesis of many illnesses, this …

ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

G **ong, Z Wu, J Yi, L Fu, Z Yang, C Hsieh… - Nucleic acids …, 2021 - academic.oup.com
Because undesirable pharmacokinetics and toxicity of candidate compounds are the main
reasons for the failure of drug development, it has been widely recognized that absorption …

Modeling the expansion of virtual screening libraries

J Lyu, JJ Irwin, BK Shoichet - Nature chemical biology, 2023 - nature.com
Recently,'tangible'virtual libraries have made billions of molecules readily available.
Prioritizing these molecules for synthesis and testing demands computational approaches …

ADMET modeling approaches in drug discovery

LLG Ferreira, AD Andricopulo - Drug discovery today, 2019 - Elsevier
Highlights•ADMET modeling plays a pivotal part in drug discovery.•Chemoinformatics has
evolved into robust machine learning approaches.•Comprehensive web-based platforms for …

Properties of FDA-approved small molecule protein kinase inhibitors

R Roskoski Jr - Pharmacological research, 2019 - Elsevier
Because mutations, overexpression, and dysregulation of protein kinases play essential
roles in the pathogenesis of many illnesses, this enzyme family has become one of the most …

A drug-likeness toolbox facilitates ADMET study in drug discovery

CY Jia, JY Li, GF Hao, GF Yang - Drug discovery today, 2020 - Elsevier
Highlights•Online resources facilitate in silico drug-likeness study.•Databases gathering
high quality and up to date data are essential for drug-likeness evaluation.•Web servers for …

ADMET-score–a comprehensive scoring function for evaluation of chemical drug-likeness

L Guan, H Yang, Y Cai, L Sun, P Di, W Li, G Liu… - …, 2019 - pubs.rsc.org
Chemical absorption, distribution, metabolism, excretion, and toxicity (ADMET), play key
roles in drug discovery and development. A high-quality drug candidate should not only …

Properties of FDA-approved small molecule protein kinase inhibitors: A 2021 update

R Roskoski Jr - Pharmacological research, 2021 - Elsevier
Owing to the dysregulation of protein kinase activity in many diseases including cancer, the
protein kinase enzyme family has become one of the most important drug targets in the 21st …

Two decades under the influence of the rule of five and the changing properties of approved oral drugs: miniperspective

MD Shultz - Journal of Medicinal Chemistry, 2018 - ACS Publications
Two decades have passed since the rule of five ushered in the concept of “drug-like”
properties. Attempts to quantify, correlate, and categorize molecules based on Ro5 …